Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S A Halperin

Showing results (71-80 of 93) with videos related to

Pageof 10
Sort By:
The Journal of Infectious Diseases|July 7, 2000
Morbidity of pertussis in adolescents and adultsG De Serres, R Shadmani, B Duval, et al.
The American Review of Respiratory Disease|November 1, 1985
Exacerbations of asthma in adults during experimental rhinovirus infectionS A Halperin, P A Eggleston, P Beasley, et al.
Vaccine|September 23, 2015
Universal tetanus, diphtheria, acellular pertussis (Tdap) vaccination of adults: What the Canadian public knows and wants to knowB A Halperin, D MacDougall, D MacKinnon-Cameron, et al.
Vaccine|March 12, 1999
A single dose of an effective whole cell pertussis vaccine does not significantly increase protection in children primed with a less effective vaccineM Rochette, G De Serres, P Duclos, et al.
Human Vaccines & Immunotherapeutics|May 14, 2021
Public awareness, attitudes, beliefs, and behaviors regarding the role of pharmacists as immunizersA M Di Castri, D M Halperin, L Ye, et al.
BMJ Open|October 1, 2015
The challenge of vaccinating adults: attitudes and beliefs of the Canadian public and healthcare providersD M MacDougall, B A Halperin, D MacKinnon-Cameron, et al.
Human Vaccines|October 3, 2006
Safety and immunogenicity of a pentavalent combination vaccine (diphtheria, tetanus, acellular pertussis, polio, and haemophilus influenzae type B conjugate) when administered as a fourth dose at 15 to 18 months of ageD W Scheifele, S A Halperin, E Rubin, et al.
Vaccine|January 5, 2000
An adult formulation of a five-component acellular pertussis vaccine combined with diphtheria and tetanus toxoids is safe and immunogenic in adolescents and adultsS A Halperin, B Smith, M Russell, et al.
Human Vaccines & Immunotherapeutics|January 27, 2016
Routine immunization of adults by pharmacists: Attitudes and beliefs of the Canadian public and health care providersD MacDougall, B A Halperin, J Isenor, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 28, 2011
Kinetics of the antibody response to tetanus-diphtheria-acellular pertussis vaccine in women of childbearing age and postpartum womenB A Halperin, A Morris, D Mackinnon-Cameron, et al.
Pageof 10

Showing results (71-80 of 93) with videos related to

Sort By:
Pageof 10
The Journal of Infectious Diseases|July 7, 2000
Morbidity of pertussis in adolescents and adultsG De Serres, R Shadmani, B Duval, et al.
The American Review of Respiratory Disease|November 1, 1985
Exacerbations of asthma in adults during experimental rhinovirus infectionS A Halperin, P A Eggleston, P Beasley, et al.
Vaccine|September 23, 2015
Universal tetanus, diphtheria, acellular pertussis (Tdap) vaccination of adults: What the Canadian public knows and wants to knowB A Halperin, D MacDougall, D MacKinnon-Cameron, et al.
Vaccine|March 12, 1999
A single dose of an effective whole cell pertussis vaccine does not significantly increase protection in children primed with a less effective vaccineM Rochette, G De Serres, P Duclos, et al.
Human Vaccines & Immunotherapeutics|May 14, 2021
Public awareness, attitudes, beliefs, and behaviors regarding the role of pharmacists as immunizersA M Di Castri, D M Halperin, L Ye, et al.
BMJ Open|October 1, 2015
The challenge of vaccinating adults: attitudes and beliefs of the Canadian public and healthcare providersD M MacDougall, B A Halperin, D MacKinnon-Cameron, et al.
Human Vaccines|October 3, 2006
Safety and immunogenicity of a pentavalent combination vaccine (diphtheria, tetanus, acellular pertussis, polio, and haemophilus influenzae type B conjugate) when administered as a fourth dose at 15 to 18 months of ageD W Scheifele, S A Halperin, E Rubin, et al.
Vaccine|January 5, 2000
An adult formulation of a five-component acellular pertussis vaccine combined with diphtheria and tetanus toxoids is safe and immunogenic in adolescents and adultsS A Halperin, B Smith, M Russell, et al.
Human Vaccines & Immunotherapeutics|January 27, 2016
Routine immunization of adults by pharmacists: Attitudes and beliefs of the Canadian public and health care providersD MacDougall, B A Halperin, J Isenor, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 28, 2011
Kinetics of the antibody response to tetanus-diphtheria-acellular pertussis vaccine in women of childbearing age and postpartum womenB A Halperin, A Morris, D Mackinnon-Cameron, et al.
Pageof 10